Theriva Biologics Inc. (TOVX)
AMEX: TOVX
· Real-Time Price · USD
0.49
-0.02 (-3.54%)
At close: Jul 24, 2025, 3:59 PM
Theriva Biologics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 154K | 154K | 758K | 758K | 758K | 758K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 148K | 187K | 149K | 250K | 343K | 418K | 404K | 294K | 181K | 85K | 73K | 67K | 72K | 87K | 74K | 56K | 33K |
Gross Profit | 39K | n/a | 642K | 508K | 415K | 340K | -404K | -294K | -181K | -85K | -73K | -67K | -72K | -87K | -74K | -56K | -33K |
Operating Income | -25.37M | -26.35M | -27.64M | -23.98M | -21.31M | -21.09M | -22.55M | -23.34M | -22.51M | -21.58M | -19.52M | -17.78M | -15.99M | -14.27M | -11.14M | -9.98M | -9.67M |
Interest Income | 565K | 697K | 871K | 1.09M | 1.3M | 1.44M | 1.44M | 1.23M | 875K | 513K | 200K | 32K | 8K | 6K | 4K | 2K | 6K |
Pretax Income | -24.81M | -25.65M | -27.12M | -23.22M | -20.35M | -19.99M | -21.1M | -22.12M | -21.64M | -21.11M | -19.36M | -17.78M | -16M | -14.27M | -11.14M | -9.97M | -9.66M |
Net Income | -24.81M | -25.65M | -26.69M | -22.27M | -19.04M | -18.35M | -18.46M | -19.85M | -19.73M | -19.57M | -19.24M | -17.81M | -16.05M | -14.27M | -11.11M | -9.94M | -9.62M |
Selling & General & Admin | 6.95M | 7.4M | 7.31M | 5.22M | 6.44M | 6.74M | 9.36M | 11.59M | 10.4M | 9.86M | 8.09M | 6.94M | 6.71M | 6.47M | 5.14M | 5.03M | 5.05M |
Research & Development | 11.54M | 12.03M | 13.34M | 14.61M | 14.79M | 14.31M | 13.19M | 11.75M | 12.1M | 11.72M | 11.43M | 10.83M | 9.28M | 7.8M | 6M | 4.94M | 4.61M |
Other Expenses | 6.92M | 6.92M | 6.92M | 4.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 18.38M | 19.32M | 20.58M | 19.79M | 21.23M | 21.05M | 22.55M | 23.34M | 22.51M | 21.58M | 19.52M | 17.78M | 15.99M | 14.27M | 11.14M | 9.98M | 9.67M |
Interest Expense | n/a | n/a | 408K | 408K | 408K | 408K | n/a | n/a | n/a | 21K | 21K | 21K | 21K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 197K | 158K | -259K | -259K | -417K | -378K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 25.49M | 26.46M | 27.64M | 23.98M | 21.31M | 21.09M | 22.55M | 23.34M | 22.51M | 21.58M | 19.52M | 17.78M | 15.99M | 14.27M | 11.14M | 9.98M | 9.67M |
Income Tax Expense | 1K | -3.28K | -428.28K | -955.28K | -1.31M | -1.64M | -2.95M | -2.58M | -2.23M | -1.85M | -129K | 23K | 31K | -14K | -24K | -32K | -48K |
Shares Outstanding (Basic) | 2.78M | 1.35M | 1.13M | 775K | 685.9K | 685.92K | 681.71K | 606.65K | 604.96K | 629.19K | 15.84M | 15.84M | 13.82M | 13.2M | 13.2M | 13.2M | 9.08M |
Shares Outstanding (Diluted) | 2.78M | 1.35M | 1.13M | 775.74K | 685.9K | 685.92K | 681.71K | 606.65K | 604.96K | 629.19K | 15.84M | 15.84M | 13.82M | 13.2M | 13.2M | 13.2M | 9.08M |
EPS (Basic) | -3.38 | -9.36 | -33.09 | -31.13 | -28.76 | -28.63 | -29.52 | -24.97 | -16.9 | -9.81 | -1.32 | -1.27 | -1.2 | -1.17 | -1.77 | -2.6 | -3.92 |
EPS (Diluted) | -3.35 | -9.33 | -33.06 | -31.1 | -28.76 | -28.63 | -29.52 | -24.97 | -16.9 | -9.81 | -1.32 | -1.27 | -1.2 | -1.17 | -1.77 | -2.6 | -3.92 |
EBITDA | -18.35M | -19.29M | -20.61M | -19.82M | -21.26M | -21.05M | -22.18M | -22.92M | -22.11M | -21.2M | -19.46M | -17.75M | -15.92M | -14.19M | -11.04M | -9.84M | -9.49M |
EBIT | -13.9M | -19.3M | -21.07M | -19.86M | -21.26M | -21.05M | -22.16M | -23.31M | -22.52M | -21.59M | -19.53M | -17.82M | -15.99M | -14.27M | -11.14M | -9.98M | -9.67M |
Depreciation & Amortization | 98K | 137K | 149K | 250K | 343K | 418K | 404K | 294K | 181K | 85K | 73K | 67K | 72K | 87K | 106K | 141K | 176K |